
Breakingviews By                     
REUTERS

SEPT. 23, 2015
The high cost of treatment for uncommon illnesses has come under attack. Rob Cyran and Jeffrey Goldfarb discuss whether political pushback will derail the booming industry.We’re interested in your feedback on this page. Tell us what you think.See More »